Health technology assessments of insulin pump and CGM
The TLV has been commissioned by the government to evaluate the cost-effectiveness of insulin pumps. We have expanded this commission to also apply to continuous glucose monitoring (CGM) and sensor-augmented insulin pump therapy (SAP), which involves the insulin pump being combined with CGM.
Page information
- Published
- 6 February 2014